Cat.#: ACPP-1450
Despition | BMP13 Human Recombinant |
SIZE | 10 µg |
Purity | > 95.0% (SDS-PAGE) |
Form | Sterile Filtered White lyophilized (freeze-dried) powder. |
Storage | Lyophilized was stored and desiccated below -18°C. |
Shipping | Shipped at 4°C |
Citation Guidance | If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. |
Cat.# | Name | Size | Price |
---|---|---|---|
ACPP-1709 | Human GPC4 Protein (AC1709) | 2 µg | inquiry |
ACPP-1638 | Human CNTF Protein (AC1638) | 5 µg | inquiry |
ACPP-1186 | Olig2 Blocking Peptide (AC1186) | 250 µg | inquiry |
ACPP-1287 | Dopamine Receptor D1 Blocking Peptide (AC1287) | 250 µg | inquiry |
ACPP-1331 | GPR56 Blocking Peptide (AC1331) | 250 µg | inquiry |
ACPP-1787 | Exenatide (AC1787) | 1 mg | inquiry |
ACPP-1246 | Bestrophin Blocking Peptide (AC1246) | 250 µg | inquiry |
ACPP-1798 | Human LMX1B Protein (AC1798) | 5 µg | inquiry |
ACPP-1126 | Recombinant Human Peripherin Protein (AC1126) | 25 µl | inquiry |
ACPP-1829 | Human SNAPIN Protein (AC1829) | 10 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.